Condition: Non Small Cell Lung Cancer · Breast Cancer · Colorectal Cancer · Sponsor: Gene Solutions
This is an observational clinical trial, aiming to investigate whether the ctDNA dynamics could predict early response to ICIs in patients with advanced-stage cancer. Moreover, conventional tumor markers PD-L1, TMB and MSI are to be investigated for their combined prognostic values in ICI treatment.
This description comes directly from the study's public registry record.
Lan NL Tu, PHD · +84888843489 · lantu@genesolutions.vn
VAN T Phan, MSc · +84908145990 · vanphan@genesolutions.vn
Always discuss trial participation with your own doctor first.
| University of Medicine and Pharmacy at HCMC | Ho Chi Minh City, Hồ Chí Minh, Vietnam | Recruiting |
| Medical Genetics Institute | Ho Chi Minh City, Vietnam | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06227728